Come up with a name for your new list and we'll add to it:
NsGene raised a round of funding on November 26, 2013. Investors include
Karin & Sten Mortstedt CBD Solutions.
NsGene, a biotech company based in Denmark and Providence, will develop its BrainRepair platform to treat cortico-basal degeneration, a rare neurological disorder with symptoms similar to Parkinson's …